939 results
·
33ms
·
Sources: EU EUDAMED, US FDA
Filters
Classification: FDA Class 2
×
BIOSCOPE SD TENS, ARISTA SD PLUS, AP-102080T
FDA 510(k)
FDA Class 2
·Neurology
AEMS V, EMS-1000, MODEL TS-140500 AND AEMS VI, EMS-1000 PLUS, MODEL TS-140600
FDA 510(k)
FDA Class 2
·Physical Medicine
APEX MEDICAL LCD TENS-VII
FDA 510(k)
FDA Class 2
·Neurology
ACU-STIM TENS, AP-101082T
FDA 510(k)
FDA Class 2
·Neurology
BESTNEB PORTABLE AEROSOL THERAPY UNIT, AP-100100
FDA 510(k)
FDA Class 2
·Anesthesiology
MODIFICATION TO:APEX MEDICAL IF-4100
FDA 510(k)
FDA Class 2
·Neurology
COM-PATCH
FDA 510(k)
FDA Class 2
·Neurology
MS104A, NEWMINI II (EMS-II), MODEL AP-101050T AND MEDTRIM (EMS-V), MODEL AP-102050T
FDA 510(k)
FDA Class 2
·Physical Medicine
Geonic Nasal Aspirator, Geonic Nasal Cleaner
FDA 510(k)
FDA Class 2
·General, Plastic Surgery
APEX MEDICAL DIGITAL TENS TS1211, TS1212
FDA 510(k)
FDA Class 2
·Neurology
APEX MEDICAL DIGITAL EMS TS1311, TS1312
FDA 510(k)
FDA Class 2
·Physical Medicine
MICRO II MICROCURRENT TENS
FDA 510(k)
FDA Class 2
·Neurology
Algesimeter, Powered
FDA classification
FDA Class 2
·Algesimeter, Powered
Detector And Alarm, Arrhythmia
FDA classification
FDA Class 2
·Detector And Alarm, Arrhythmia
Prosthesis, Vascular Graft, Of 6mm And Greater Diameter
FDA classification
FDA Class 2
·Prosthesis, Vascular Graft, Of 6mm And Greater Diameter
Prostate-Specific Antigen (Psa) For Management Of Prostate Cancers
FDA classification
FDA Class 2
·Prostate-Specific Antigen (Psa) For Management Of Prostate Cancers
Early Growth Response Gene 1 (Egr1) Fish Probe Kit For Specimen Characterization
FDA classification
FDA Class 2
·Early Growth Response Gene 1 (Egr1) Fish Probe Kit For Specimen Characterization
Early Growth Response 1 (Egr) Fish Probe Kit
FDA classification
FDA Class 2
·Early Growth Response 1 (Egr) Fish Probe Kit
Prostate-Specific Antigen (Psa) For Prognostic, Recurrence Risk Assessment Of Prostate Cancers
FDA classification
FDA Class 2
·Prostate-Specific Antigen (Psa) For Prognostic, Recurrence Risk Assessment Of Prostate Cancers